Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
AIDS Care. 2022 Apr;34(4):430-439. doi: 10.1080/09540121.2021.1887443. Epub 2021 Mar 10.
This mixed methods study aimed to evaluate the feasibility and preliminary efficacy of a fully automated, interactive smartphone-delivered intervention for smoking cessation among people living with HIV in Cambodia. We used the explanatory sequential design, with a pilot two-group single-blind randomized controlled trial ( = 50) followed by in-depth interviews with all trial participants. In the trial, participants were randomized to Standard Care (SC) or Automated Messaging (AM) group. SC comprised brief advice to quit and self-help materials. AM consisted of the SC components plus a fully automated smartphone-based treatment program that involved interactive and tailored proactive messaging for 2 months. Results showed that the AM approach was highly feasible and efficacious. Feasibility was supported by high rates of treatment engagement (e.g., 81% of delivered messages and assessments were read or completed) and high retention (96%) through the 2-month follow-up. Biochemically verified point prevalence abstinence at follow-up was 40% for the AM group and 8% for the SC group (relative risk: 5.0, 95% confidence interval: 1.2, 20.5). Being able to avoid other smokers, having coping skills, and having social/familial support contributed to successful abstinence. The AM program has the potential for wide-scale implementation in Cambodia and other low-income countries.
这项混合方法研究旨在评估一种完全自动化、互动式智能手机戒烟干预措施在柬埔寨 HIV 感染者中的可行性和初步疗效。我们采用了解释性序贯设计,首先进行了一项两臂单盲随机对照试验( = 50)的试点研究,然后对所有试验参与者进行了深入访谈。在试验中,参与者被随机分配到标准护理(SC)组或自动短信(AM)组。SC 组包括简短的戒烟建议和自助材料。AM 组包括 SC 组的所有内容,再加上一个完全自动化的基于智能手机的治疗方案,该方案包括为期 2 个月的互动和个性化主动短信。结果表明,AM 方法具有高度的可行性和疗效。高治疗参与率(例如,81%的发送消息和评估被阅读或完成)和 96%的高保留率(通过 2 个月的随访)支持了可行性。在随访时,AM 组的生物化学验证点患病率为 40%,而 SC 组为 8%(相对风险:5.0,95%置信区间:1.2,20.5)。能够避免其他吸烟者、有应对技能以及得到社会/家庭支持有助于成功戒烟。AM 方案有可能在柬埔寨和其他低收入国家广泛实施。